|
|
|
Insider
Information: |
Golkin Perry |
Relationship: |
see footnotes |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
20,500 |
|
Indirect Shares
|
70,086,436 |
|
|
Direct
Value |
$5,237,340 |
|
|
Indirect Value
|
$1,695,130,279 |
|
|
Total
Shares |
70,106,936 |
|
|
Total
Value |
$1,700,367,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Layne Christensen Co |
LAYN |
10% Owner |
2003-06-30 |
0 |
2003-07-01 |
121,741 |
Premium* |
|
Amphenol Corp |
APH |
10% Owner |
2003-08-15 |
0 |
2004-02-23 |
4,350,628 |
Premium* |
|
Willis Towers Watson Public Limi... |
WLTW |
Director |
2005-06-13 |
20,500 |
2005-11-16 |
1,194,987 |
Premium* |
|
Accuride Corp |
ACW |
See footnote 1 |
|
0 |
2005-10-12 |
7,850,213 |
Premium* |
|
Sealy Corp |
ZZ |
10% Owner |
2006-04-06 |
0 |
2006-04-11 |
46,625,921 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
see footnotes |
2008-07-21 |
0 |
2008-07-21 |
9,942,946 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACW |
Accuride Corp |
10% Owner |
|
2005-04-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,765,600 |
|
- |
|
WLTW |
Willis Towers Watson Publ... |
Director |
|
2003-05-06 |
4 |
S |
$31.00 |
$662,997,248 |
I/I |
(21,387,008) |
37,682,029 |
|
- |
|
WLTW |
Willis Towers Watson Publ... |
Director |
|
2003-05-15 |
4 |
S |
$31.00 |
$66,299,731 |
I/I |
(2,138,701) |
35,543,328 |
|
- |
|
LAYN |
Layne Christensen Co |
10% Owner |
|
2003-06-30 |
4 |
S |
$8.00 |
$12,441,600 |
I/I |
(1,555,200) |
175,236 |
|
- |
|
LAYN |
Layne Christensen Co |
10% Owner |
|
2003-07-01 |
4 |
S |
$8.07 |
$431,705 |
I/I |
(53,495) |
121,741 |
|
- |
|
APH |
Amphenol Corp |
10% Owner |
|
2003-08-15 |
4 |
D |
$50.00 |
$448,536,100 |
I/I |
(8,970,722) |
11,910,628 |
|
- |
|
APH |
Amphenol Corp |
10% Owner |
|
2004-02-23 |
4 |
D |
$60.00 |
$453,600,000 |
I/I |
(7,560,000) |
4,350,628 |
|
- |
|
WLTW |
Willis Towers Watson Publ... |
Director |
|
2004-02-25 |
4 |
S |
$37.03 |
$882,882,119 |
I/I |
(23,844,923) |
11,732,405 |
|
- |
|
WLTW |
Willis Towers Watson Publ... |
Director |
|
2004-03-22 |
4 |
S |
$37.03 |
$110,360,251 |
I/I |
(2,980,615) |
8,751,790 |
|
- |
|
WLTW |
Willis Towers Watson Publ... |
Director |
|
2005-06-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,500) |
20,500 |
|
- |
|
ACW |
Accuride Corp |
See footnote 1 |
|
2005-10-05 |
4 |
S |
$13.25 |
$56,633,813 |
I/I |
(4,274,250) |
8,491,350 |
|
- |
|
ACW |
Accuride Corp |
See footnote 1 |
|
2005-10-12 |
4 |
S |
$13.25 |
$8,495,065 |
I/I |
(641,137) |
7,850,213 |
|
- |
|
WLTW |
Willis Towers Watson Publ... |
Director |
|
2005-11-16 |
4 |
S |
$36.00 |
$271,558,908 |
I/I |
(7,543,303) |
1,194,987 |
|
- |
|
ZZ |
Sealy Corp |
10% Owner |
|
2006-04-06 |
4 |
B |
$16.00 |
$2,336,000 |
I/I |
146,000 |
146,000 |
1.5 |
- |
|
ZZ |
Sealy Corp |
10% Owner |
|
2006-04-06 |
4 |
S |
$16.00 |
$106,114,080 |
I/I |
(6,632,130) |
50,107,789 |
|
- |
|
ZZ |
Sealy Corp |
10% Owner |
|
2006-04-11 |
4 |
S |
$16.00 |
$55,709,888 |
I/I |
(3,481,868) |
46,625,921 |
|
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
see footnotes |
|
2008-07-21 |
4 |
B |
$0.00 |
$0 |
I/I |
1,328,527 |
9,906,501 |
0.01 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|